Skin external agents and drugs
    3.
    发明授权
    Skin external agents and drugs 失效
    皮肤外用剂和药物

    公开(公告)号:US07037489B2

    公开(公告)日:2006-05-02

    申请号:US10169040

    申请日:2000-12-15

    IPC分类号: A61K31/74 A61K6/00

    摘要: Skin external agent compositions and drugs characterized by containing fumaric acid diester derivatives represented by following general formula (1), wherein R1 represents C1-4 alkylene; R2 and R3 represent each liner or branched C1-8 alkyl; and n is an integer of 2 to 5; which provide epidermal barrier function potentiating agents and skin external agent compositions having a high safety, quickly relieving epidermal permeation barrier function failures and having an effect of maintaining the skin in a cosmetologically healthy state; agents to be used together with HB-EFG expression inducing agents accelerating epidermal turnover, amphiregulin expression inhibitors regulating excessive epidermal proliferation, and retinoic acid or its derivative preventing skin chapping caused by retinoic acid or its derivative; and skin aging relieving agents capable of ameliorating depression in the skin metabolism and thinning in association with aging.

    摘要翻译: 皮肤外用剂组合物和药物,其特征在于含有由以下通式(1)表示的富马酸二酯衍生物,其中R 1表示C 1-4烷基; R 2和R 3代表每个内衬或支链C 1-8烷基; n为2〜5的整数, 其提供表皮屏障功能增强剂和皮肤外用剂组合物,其具有高安全性,快速缓解表皮渗透屏障功能障碍并具有保持皮肤处于美观健康状态的效果; 与HB-EFG表达诱导剂加速表皮转换,调节过度表皮增生的双调蛋白表达抑制剂和视黄酸或其衍生物一起使用的药剂可以防止由视黄酸或其衍生物引起的皮肤裂伤; 以及能够改善皮肤新陈代谢抑制和与老化相关的变薄的皮肤老化缓解剂。